Study Evaluating Effexor XR in Chinese Subjects With Major Depressive Disorder
Status:
Withdrawn
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This primary purpose of this study is to assess the efficacy and safety of Effexor XR in
preventing recurrence in Chinese patients with recurrent major depressive disorder (MDD)
following a 1-year maintenance treatment after an 8-week acute treatment and a 6-month
continuation treatment phases. The study will also collect data on the prevalence and pattern
of co-morbid anxiety and somatic symptoms and their impact on the recurrence of depression.